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Abstract
Progestins bind to the progestin receptor (PR) isoforms, PR-A and PR-B, in brain to influence development,
female reproduction, anxiety, and stress. Hormone-activated PRs associate with multiple proteins to form
functional complexes. In the present study, proteins from female mouse hypothalamus that associate with PR
were isolated using affinity pull-down assays with glutathione S-transferase–tagged mouse PR-A and PR-B.
Using complementary proteomics approaches, reverse phase protein array (RPPA) and mass spectrometry, we
identified hypothalamic proteins that interact with PR in a ligand-dependent and isoform-specific manner and
were confirmed by Western blot. Synaptic proteins, including synapsin-I and synapsin-II, interacted with agonistbound PR isoforms, suggesting that both isoforms function in synaptic plasticity. In further support, synaptogyrinIII and synapsin-III associated with PR-A and PR-B, respectively. PR also interacted with kinases, including c-Src,
mTOR, and MAPK1, confirming phosphorylation as an integral process in rapid effects of PR in the brain.
Consistent with a role in transcriptional regulation, PR associated with transcription factors and coactivators in a
ligand-specific and isoform-dependent manner. Interestingly, both PR isoforms associated with a key regulator
of energy homeostasis, FoxO1, suggesting a novel role for PR in energy metabolism. Because many identified

Significance Statement
Progesterone binds to the progestin receptor (PR) isoforms, PR-A and PR-B, in the brain to profoundly
influence female reproduction, brain development, neuroprotection, and stress. We combined mass
spectrometry and reverse phase protein arrays to identify mouse hypothalamic proteins that function in
synaptic plasticity, transcription, translation, and energy metabolism and interacted with PR in a liganddependent and isoform-specific manner. In addition, progesterone increased synaptic density in primary
cortical neurons, suggesting a function for progesterone in synapse formation in cortical neurons. Taken
together, these findings provide evidence for novel functions of PR in synaptic modulation and energy
homeostasis to affect health and disease.
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proteins in this PR interactome are synaptic proteins, we tested the hypothesis that progestins function in
synaptic plasticity. Indeed, progesterone enhanced synaptic density, by increasing synapsin-I–positive synapses,
in rat primary cortical neuronal cultures. This novel combination of RPPA and mass spectrometry allowed
identification of PR action in synaptic remodeling and energy homeostasis and reveals unique roles for progestins
in brain function and disease.
Key words: Cortex; estrogen; progesterone; proteomics; synapse; synapsin

Introduction
Progestins, a class of steroid hormones, act in the brain
to profoundly influence development (Beyer et al., 2002;
Wagner, 2006); neuroprotection (Stein and Hoffman, 2003;
Singh, 2006; Irwin et al., 2008; Su et al., 2012); reproductive
behavior (Sinchak and Micevych, 2001; Blaustein, 2008);
learning, memory, and cognition (Hull et al., 1980; Sandstrom and Williams, 2001; Wagner, 2006); and anxiety and
stress (Mora et al., 1996; Blaustein and Ismail, 2013; Keyes
et al., 2013; Uphouse et al., 2013). In addition, progestins
have been implicated in a variety of human diseases, including neurodegeneration and breast cancer (Richer et al.,
2002; Brinton et al., 2008; Obr and Edwards, 2012; Diep
et al., 2015).
Progestins elicit many of their effects by binding to
progestin receptors (PR), which exist as two isoforms in
mammals, an N-terminally truncated PR-A and a fulllength PR-B (Tetel and Lange, 2009). Both isoforms share
a C-terminal ligand binding domain, a DNA binding domain, and two transactivation domains (Horwitz et al.,
1990; Kastner et al., 1990). Interestingly, a third transactivation domain exclusive to PR-B, and a PR-A specific
inhibitory region, have been identified, allowing differential functions by the isoforms (Hovland et al., 1998).
Isoform-specific transcriptional activation by PR has
been observed in vitro and in vivo (Sartorius et al., 1994;
Giangrande et al., 1997; Conneely et al., 2000; Cheng
et al., 2001; Richer et al., 2002; Mulac-Jericevic et al.,
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though PR-A in the mouse hypothalamus is the primary
mediator of female sexual behavior, both isoforms are
required for the full behavioral response (Mani et al.,
2006). In support, PR-A and PR-B are differentially
expressed in the female mouse hypothalamus (Acharya
et al., 2015).
PR associate with multiple proteins, including nuclear
receptor coactivators, which stabilize the receptor complex and enhance transcription (Hill et al., 2012; Goswami
et al., 2014; Simons et al., 2014). In the female mouse
hypothalamus, the PR isoforms are differentially expressed with steroid receptor coactivator-1 (SRC-1, also
named NCOA1) and SRC-2 (NCOA2; Acharya et al.,
2015). In addition, SRC-1 and SRC-2 from hypothalamus
associate with the PR isoforms in a ligand-dependent and
isoform-specific manner (Molenda-Figueira et al., 2008;
Yore et al., 2010) and modulate hormone-dependent gene
expression and female sexual behavior (Apostolakis et al.,
2002; Molenda et al., 2002; Molenda-Figueira et al., 2006).
Taken together, these studies indicate that nuclear receptor coactivators are important in PR function in the brain.
PR act through both classic and nonclassic pathways in
the brain and other progestin-responsive tissues. For example, in the hypothalamus, PR activation induces lordosis in female rodents through transcriptional regulation
(Leonhardt et al., 2003; Molenda-Figueira et al., 2006) as
well as nonclassic kinase activation (González-Flores
et al., 2004; Mani et al., 2006). PRs are present in synapses (Waters et al., 2008; Mitterling et al., 2010) and
rapidly alter dendritic spine densities in rat hippocampus
(Woolley and McEwen, 1993; McEwen and Woolley,
1994), cortical neurons (Chen et al., 2009; Sanchez et al.,
2013), and hypothalamus (Griffin et al., 2010).
Although we are gaining a better understanding of distinct functions of the PR isoforms in brain, little is known
about the mechanisms involved. Therefore, to investigate
the factors that could contribute to the differential function
of the PR isoforms in brain, we have combined mass
spectrometry (MS) and reverse phase protein array
(RPPA) in a functional proteomic analysis to identify proteins from adult female mouse hypothalamus that interact
with mouse PR-A and PR-B. In addition, given the identification of many synaptic proteins that interact with PR in
the present study, we tested the hypothesis that progestins influence synaptic plasticity by increasing synapse
formation in cortical neurons.

Materials and Methods
Animals
Female C57/BL6 mice were bred in the Wellesley College Animal Facility (Wellesley, MA). Mice were grouphoused (three to six/group) under a 12-h light/dark cycle.
eNeuro.org
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Food and water were available ad libitum. All animal
procedures were approved by the Institutional Animal
Care and Use Committee of Wellesley College and were
conducted in accordance with the National Institutes of
Health Guide for the Care and Use of Laboratory Animals.
Tissue collection and preparation
Mice (8 to 10 wks old) were bilaterally ovariectomized
under 1.5% isoflurane. One week later, mice were killed
by asphyxiation under CO2. Brains were quickly removed,
and hypothalamic tissue was dissected using coordinates
from the mouse brain atlas (Paxinos and Franklin, 2004),
immediately frozen on dry ice, and stored at – 80°C until
homogenization. Hypothalami from four to eight mice
were pooled to generate each sample and lysed in lysis
buffer containing 10 mM Tris, 10% glycerol, 400 mM NaCl,
1 mM dithiothreitol (DTT), and 1 mM EDTA (pH 7.4) with
protease inhibitors (1:10 dilution, P2714, Sigma-Aldrich).
Lysates were incubated on ice for 30 min followed by
centrifugation at 13,200 ⫻ g for 30 min at 4°C. Supernatants containing proteins were stored at – 80°C.
Glutathione S-transferase–tagged mouse progestin
receptors
Mouse PR-B cDNA was cloned into the CMV-based
mammalian cell expression plasmid pcDNAI (Invitrogen)
by insertion into the PspHI/EcoRI site. Mouse PR-A cDNA
was prepared by partial digest of mouse PR-B cDNA,
ligated into the pBlueBacHis2B transfer plasmid, and inserted into the BamHI/EcoRV site of pcDNAI. pAcG2T
baculovirus expression vector (BD Biosciences) was used
for expression of PR-A and PR-B as fusion proteins,
containing an N-terminal glutathione S-transferase (GST) tag.
Site-directed mutations were performed using QuikChange XL
Site-directed Mutagenesis Kit (Stratagene). The mutated
sites were used to ligate cDNAs of mouse PR-A and PR-B
into the respective restriction sites of pAcG2T. Mouse
PR-A containing BamHI and EcoRI sites was ligated into
the respective sites of the mutated pAcG2T. Similarly,
mouse PR-B containing EcoRI and NotI sites was ligated
into the respective sites of the mutated pAcG2T. Both
DNA constructs were fully sequenced from the start of the
GST to the end of the mouse PR subtype (Genewiz).
After the full sequences were confirmed, recombinant
proteins containing full-length mouse PR-A or PR-B fused
to a GST tag were expressed in Spodoptera frugiperda
(Sf9) insect cells by the Baculovirus/Monoclonal Antibody
Facility of the Baylor College of Medicine as described
previously (Tetel et al., 1999; Molenda-Figueira et al.,
2008; Yore et al., 2010). Insect cell cultures for GST-PR
were incubated with saturating doses of 200 nM of the PR
agonist R5020 or in the absence of PR ligand. Sf9 cell
pellets were homogenized in buffer containing 10 mM Tris,
10% glycerol, 400 mM NaCl, 1 mM DTT, and 1 mM EDTA
(pH 7.4) with protease inhibitors. Homogenates were
incubated on ice for 30 min, and then centrifuged at
13,200 ⫻ g for 30 min at 4°C. Supernatants containing
proteins were stored at – 80°C.
September/October 2017, 4(5) e0272-17.2017

3 of 19

GST-PR pull-down
GST-PR pull-down assays were performed as described previously (Molenda-Figueira et al., 2008; Yore
et al., 2010). Briefly, glutathione Sepharose 4B packed
resin (50 L, 0.05 mg/mL, GE Healthcare) was added to
siliconized centrifuge tubes and pretreated with ovalbumin (1 mg/mL, Thermo Fisher Scientific) for 15 min on an
end-over-end rotator at 4°C. Resin was rinsed three times
with TG buffer (20 mM Tris–HCl and 10% glycerol) containing 1 M urea and 100 mM NaCl (TG-NaCl-U, pH 8.0).
GST-PRA or GST-PRB bound to the agonist R5020, or
unliganded, were used for pull-downs. R5020 is a synthetic progestin that binds with a similar affinity to both
PR-A and PR-B (Skafar, 1991; Carbajo et al., 1996). Equal
amounts of recombinant mouse GST-PR suspended in
TG buffer with 1 M urea (TG-U, pH 8.0) were added to
resin and incubated on a rotator at 4°C for 1 h. After
incubation, resin with immobilized GST-PR was washed
four times with TG-NaCl-U (with reducing urea concentrations of 1, 0.5, 0.25, and 0 M). Equal amounts of pooled
hypothalamic homogenates were added to immobilized
GST-PR and incubated on a rotator for 1 h at 4°C. The
resins were washed four times with TG-NaCl (without
urea).
Proteins bound to GST-PR resin were eluted in specific
buffers for each of the analyses. For Western blots, samples were eluted by boiling for 5 min in 2⫻ Laemmli
sample buffer (Bio-Rad) with 35 mM DTT (Sigma-Aldrich)
for 5 min. For MS analysis, GST-PR and proteins bound to
resin were eluted by incubating in 250 mM glutathione
elution buffer (in 50 mM Tris-HCl, pH 8.0) at 4°C for 10 min.
Samples for RPPA analysis were boiled in SDS sample
buffer (Invitrogen) with 2.5% ␤-mercaptoethanol for 5 min.
Mass spectrometry analysis
Pull-down assays for MS were performed with GSTPRA or GST-PRB, unliganded or bound to R5020. Tryptic
peptides prepared as previously described (MolendaFigueira et al., 2008) for each receptor type and ligand
condition were block-randomized and analyzed in triplicate (Oberg and Vitek, 2009) by nano-LC-MS/MS using a
nano-LC chromatography system (UltiMate 3000 RSLCnano,
Dionex), coupled online to a Thermo Orbitrap Fusion mass
spectrometer (Thermo Fisher Scientific) through a nanospray ion source (Thermo Fisher Scientific). Chromatographic columns were made from 75-m-ID polyimidecoated fused silica capillary (Polymicro Technologies)
packed with 5 m Zorbax SB-C18 reversed-phase packing (Agilent) to a length of 10 cm by using a Pressure
Injection Cell (NextAdvance). The trap column was prepared in the same manner but to a length of 1 cm. After
equilibrating the column in 98% solvent A (0.1% formic
acid in water) and 2% solvent B (0.1% formic acid in
acetonitrile), the samples (3 L in solvent A) were injected
onto the trap column and eluted (400 nL/min) by gradient
elution onto the C18 column as follows: isocratic at 2% B,
0 –5 min; 2% to 32% B, 5– 49 min; 32% to 90% B, 49 –50
min; isocratic at 90% B, 50 –54.5 min; 90% to 2% B,
54.5–55 min; and isocratic at 2% B, 55– 60 min. All LCMS/MS data were acquired using XCalibur, version 2.1.0
eNeuro.org
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(Thermo Fisher Scientific) in positive ion mode using a top
speed data-dependent acquisition method with a 2-s cycle time. The survey scans (m/z 350 –1600) were acquired
in the Orbitrap at 120,000 resolution (at m/z 400) in profile
mode, with a maximum injection time of 50 ms and an
automatic gain control (AGC) target of 400,000 ions. The
S-lens RF level was set to 60. Isolation was performed in
the quadrupole with a 1.6-Da isolation window, and CID
MS/MS acquisition was performed in profile mode in the
ion trap using rapid scan rate, with the following settings:
parent threshold, 10,000; isolation width, 1.6 Da; normalized collision energy, 35%; maximum injection time, 150
ms; and AGC target, 10,000 ions. Monoisotopic precursor
selection and charge state filtering were on, with charge
states 2– 4 included. Dynamic exclusion was used to
remove selected precursor ions for 60 s after acquisition
of one MS/MS spectrum.
Proteomic data analysis of MS samples
All data files were searched against a Uniprot mouse
database (June 2014 version, 16,728 proteins), appended
with the Common Repository of Adventitious Proteins
contaminant database using PEAKS (Ma et al., 2003; Han
et al., 2004, 2011; Zhang et al., 2012). Searches were
performed with a parent ion tolerance of 10 ppm, fragment ion tolerance of 0.80 Da, fixed modification of carbamidomethyl (C), and variable modifications of oxidation
(M) and phosphorylation (STY). Trypsin was specified as
the enzyme, allowing for two missed cleavages and
one nonspecific cleavage. False discovery rate (FDR) estimation was allowed. The resulting peptide-spectrum
matches ⬎1% FDR were used to generate a spectral
library for subsequent quantitative analysis. Data files for
each pair of samples were imported into Skyline (MacLean et al., 2010) for label-free quantitative analysis
(Schilling et al., 2012). After manual verification of all
peaks, triplicate peptide intensities were used to calculate
fold changes and p-values.
Reverse phase protein array analysis
Hypothalamic tissue from adult female mice (n ⫽ 32)
was pooled into four different groups. Similar to MS,
RPPA assays were performed using pull-downs with
GST-PRA and GST-PRB bound to R5020 or unliganded.
RPPA assays were conducted as described previously
(Chang et al., 2015) with the following modifications. Proteins associating with GST-PR bound to resins were
eluted in 2⫻ Tris-glycine SDS buffer with 2.5% ␤-mercaptoethanol and mixed with modified Tissue Protein Extraction Reagent (Pierce and Xu, 2010) and a cocktail of
protease and phosphatase inhibitors (Roche Life Science;
Chang et al., 2015). A 2470 Arrayer (Aushon BioSystems)
with a 40-pin (185 m) configuration was used to spot
samples and control lysates onto nitrocellulose-coated
slides (Grace Bio-labs) using an array format of 960 lysates/slide (2880 spots/slide). The slides were processed
as described previously (Chang et al., 2015) and probed
with a set of 212 antibodies (Table 1) against 140 total
proteins and 72 proteins phosphorylated on specific sites
using an automated slide stainer, Autolink 48 (Dako). Each
slide was incubated with one specific primary antibody.
September/October 2017, 4(5) e0272-17.2017
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Negative control slides were incubated with antibody diluent instead of primary antibody. Primary antibody binding was detected using a biotinylated secondary antibody
followed by streptavidin-conjugated IRDye680 fluorophore (LI-COR Biosciences). The total protein content of
each spotted lysate was assessed by fluorescent staining
with Sypro Ruby Protein Blot Stain according to the manufacturer’s instructions (Invitrogen).
Fluorescence-labeled slides were scanned on a GenePix 4400 AL scanner. Each slide, along with its accompanying negative control slide, was scanned at an
appropriate photomultiplier tube to obtain optimal signal
for this specific set of samples. The images were analyzed
with GenePix Pro 7.0 (Molecular Devices). Total fluorescence signal intensities for each spot were obtained after
subtraction of the local background signal for each slide
and were then normalized for variation in total protein,
background, and nonspecific labeling using a groupbased normalization method as described (Chang et al.,
2015). Each image, along with its normalized data, was
evaluated for quality through manual inspection and comparison with control samples. Specific fluorescence intensity signals of 50 units or less was taken as assay cutoff
for a positive reaction, resulting in 195 remaining proteins,
of the 212 (Table 1), to be analyzed.
Analysis of data from RPPA assays
After data were normalized to PR signal in the assay or
to target protein input, it was determined that normalizing
to PR produced the most consistent results. The effects of
receptor type and hormone treatment were analyzed via
two-way ANOVA using R. We identified proteins with
FDR-adjusted p-values ⬍0.05. For this subset of identified proteins, relative fold changes between the liganded
and unliganded receptor were calculated for each isoform. For proteins displaying a positive interaction with
the liganded PR, a two-fold change was used as a cutoff.
For proteins showing a positive association with the unliganded PR, further stringency was maintained by setting
a higher threshold of three-fold change, as with the MS
data.
Western blot analysis
Western blot analyses were performed on representative proteins: synapsin-I and synapsin-II (MS-identified)
and SRC-1, SRC-2, FoxO1, MED12, c-Fos, and c-Jun
(RPPA-identified) to validate findings from the MS and
RPPA analyses. Western blots were conducted as described previously (Bless et al., 2014) with the modifications indicated below. For independent validation of the
ligand-dependent interaction of PR with hypothalamic
SRC-1 and SRC-2 determined by RPPA, protein homogenates from female mouse hypothalamus (n ⫽ 6, 5 mice
per group) were prepared as described above. Pull-down
samples were probed for SRC-1 and SRC-2 using a rabbit
polyclonal antibody to 350–690 amino acids (aa) of human
SRC-1 (1:250, #sc-8995, Santa Cruz, RRID:AB_2235896) and
a rabbit polyclonal antibody to human SRC-2 (1:750, #PA186392, Fisher Scientific, RRID:AB_2103955), respectively.
MED12, c-Fos and c-Jun were probed with rabbit polyclonal antibodies MED12 (1:200, #ab70842, Abcam),
eNeuro.org
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Table 1. List of antibodies used for RPPA analysis
Antibody name
14-3-3zeta,gamma,eta_R_V
Akt_R_V
p-Akt(S473)_R_V
p-Akt(T308)_R_V
p-ALK(3B4)(Y1586)_R_V
p-ALK(Y1604)_R_V
p-AMPKa(40H9)(T172)_R_V
p-AMPKa1(S485)_R_V
p-AMPKb1(S108)_R_V
Annexin1_R_V
ATM_R_V
ATR_R_V
p-ATR(S428)_R_V
p-AuroraA(T288)/B(T232)/C(T198)_R_V
AuroraA/AIK_R_V
p-Axl(D12B2)(Y702)_R_V
Bad_R_V
p-Bad(S112)_R_V
p-Bad(S136)_R_V
p-Bad(S155)_R_V
Bak_R_V
Bax_R_V
p-Bcl2(5H2)(S70)_R_V
p-Bcl2(T56)_R_V
BRCA1_R_V
BRCA2_R_V
Caspase-3_R_V
p-Beta-Catenin(S33/37/T41)_R_V
Caveolin-1(D46G3)XP_R_V
p-Caveolin-1(EPR2288Y)(Y14)_R_V
CD24(FL-80)_R_V
p-Chk1(S345)_R_V
p-Chk2(S33/35)_R_V
Claudin-1_R_V
c-Met_R_V
p-c-Myc(T58)_R_V
DKK1_R_V
EGFR(D38B1)XP_R_V
EGFR(L858R)_R_V
p-EGFR(S1046/1047)_R_V
p-EGFR(Y1045)_R_V
p-EGFR(Y1148)_R_V
p-EGFR(Y1173)_R_V
p-EGFR(Y1173)(53A5)_R_V
p-EGFR(Y1068)(D7A5)XP_R_V
Ezh2(D2C9)XP_R_V
FGFR1(D8E4)XP_R_V
FoxO1(C29H4)_R_V
FSP1/S100A4_R_V
p-HER2/ErbB2(Y1248)_R_V
p-HER2/ErbB2(Y877)_R_V
HER3/ErbB3_R_V
p-HER3/ErbB3(Y1197)_R_V
HDAC1_R_V
HDAC3_R_V
HDAC4_R_V
HDAC6_R_V
ILK1_R_V
p-Jak1(Y1022/1023)_R_V
Kit-c_R_V
Lipocalin-1_R_V

September/October 2017, 4(5) e0272-17.2017

Company
EMD Millipore (Upstate)
CST
CST
CST
CST
CST
CST
CST
CST
Invitrogen
Abcam
CST
CST
CST
CST
CST
CST
CST
CST
CST
CST
CST
CST
CST
EMD Millipore (Upstate)
CST
CST
CST
CST
Abcam-Epitomics
Santa Cruz Biotechnology
CST
CST
CST
Abcam
Abcam
CST
CST
CST
CST
CST
CST
Invitrogen (BioSource)
CST
CST
CST
CST
CST
EMD Millipore
CST
Imgenex
CST
CST
CST
CST
CST
Santa Cruz Biotechnology
CST
CST
Abcam
Santa Cruz Biotechnology
(Continued)

Catalog #
06-408
9272
9271
9275
3348
3341
2535
4184
4181
71-3400
ab32420
2790
2853
2914
3092
5724
9292
9291
9295
9297
3814
2772
2827
2875
07-434
9012
9662
9561
3267
2267-1
sc-11406
2341
2665
4933
ab51067
ab28842
4687
4267
3197
2238
2237
4404
44-794G
4407
3777
5246
9740
2880
Jul-74
2247
IMG-90185
4754
4561
2062
2632
2072
sc-11420
3862
3331
ab32363
sc-66943

Host
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
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Table 1. Continued
Antibody name
LRP6_R_V
MEK1_R_V
p-MEK1/2(S217/221)_R_V
p-Met(Y1234/1235)_R_V
MMP-9_R_V
mTOR_R_V
p-mTOR(D9C2)XP(S2448)_R_V
Notch1(C44H11)_R_V
p-p27(T187)_R_V
p-p27/KIP1(T198)_R_V
p27/KIP1(C-term)_R_V
p38/MAPK_R_V
p-p38(D3F9) XP(T180/Y182)_R_V
p44/42MAPK(Erk1/2)_R_V
p-p44/42MAPK(Erk1/2)(T202/Y204)(197G2)_R_V
p53_R_V
p-p53(S15)_R_V
p70S6K_R_V
p-p70S6K(S371)_R_V
p-p70S6K(T389)_R_V
p-p70S6K(T412)_R_V
p-PDGFRa(23B2)(Y754)_R_V
PDGFRb(28E1)_R_V
p-PDK1(S241)_R_V
PIAS1_R_V
PTEN(D4.3)XP_R_V
p-PTEN(S380)_R_V
p-RafB(S445)_R_V
RANKL_R_V
p-Ret(Y905)_R_V
Slug(C19G7)_R_V
p-Smad2(S465/467)_R_V
SOCS1(A156)_R_V
SOCS3_R_V
Sox2(D6D9) XP_R_V
p-Src(Y527)_R_V
Stat1_R_V
p-Stat1(Y701)_R_V
p-Stat2(Y690)_R_V
p-Stat3(S727)_R_V
p-Stat4(Y693)_R_V
p-Stat5(Y694)_R_V
Stat6_R_V
p-Stat6(Y641)_R_V
p-Tuberin/TSC2(T1462)_R_V
Vimentin(D21H3)XP_R_V
Wnt5a/b(C27E8)_R_V
YAP(H125)_R_V
ZO-1_R_V
Caspase-7_R_V
VEGFR2(55B11)_R_V
Stat5a(L-20)_R_V
SOX9_R_V
p-SAPK/JNK(T183/Y185)_R_V
Zeb1_R_V
PHF8(pAb)_R_V
ASH2_R_V
CBP(A-22)_R_V
c-Fos(9F6) _R_V
CHAF1A(D77D5)XP_R_V
c-Jun(60A8)_R_V
CRSP1-TRAP220_R_V
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Company
CST
Abcam-Epitomics
CST
CST
CST
CST
CST
CST
Invitrogen (Zymed)
Abcam
Abcam-Epitomics
CST
CST
CST
CST
CST
CST
CST
CST
CST
EMD Millipore (Upstate)
CST
CST
CST
CST
CST
CST
CST
Novus
CST
CST
CST
CST
CST
CST
CST
CST
CST
CST
CST
CST
CST
CST
CST
CST
CST
CST
Santa Cruz Biotechnology
CST
CST
CST
Santa Cruz Biotechnology
EMD Millipore (Upstate)
CST
Novus
Active Motif
Bethyl Laboratories
Santa Cruz Biotechnology
CST
CST
CST
Bethyl Laboratories
(Continued)

Catalog #
2560
1235-1
9121
3077
3852
2972
5536
3268
71-7700
ab64949
ab32034(1591-1)
9212
4511
9102
4377
9282
9284
9202
9208
9205
07-018
2992
3169
3061
3550
9188
9551
2696
NBP1-31140
3221
9585
3101
3950
2923
3579
2105
9172
9171
4441
9134
5267
9351
9362
9361
3611
5741
2530
sc-15407
5406
9491
2479
sc-1081
AB5535
4668
NBP1-05987
39711
A300-489A
sc-369
2250
5480
9165
A300-793A

Host
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
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Table 1. Continued
Antibody name
CtBP2_R_V
Cyclin C_R_V
DRIP130_R_V
FBX011_R_V
FoxK2_R_V
KLF4_R_V
MED12-Abcam_R_V
p300(C-20)_R_V
p-c-Fos(S32)_R_V
PPP1R10(EPR11706)_R_V
Stat3(D3Z2G)_R_V
p-TRAP220-MED1(T1457)_R_V
HIF-2A(D9E3)_R_V
p-c-Jun(S63)_R_V
Sin3b_R_V
p-Rb(S807/811)_R_V
p-Rb(S780)(C84F6)_R_V
p-FAK(Y576/577)_R_V
Ki67_R_V
Integrina4(D2E1)XP_R_V
Integrina5_R_V
IntegrinaV_R_V
Integrinb1(D2E5)_R_V
Integrinb3(D7X3P)XP_R_V
Integrinb4_R_V
PI3Kp85_R_V
AMPKa(23A3)_R_V
PI3Kp110a(C73F8)_R_V
ERa(SP1)_R_V
MEK6_R_V
p21_R_V
Atg12(D88H11)_R_V
Beclin-1(D40C5)_R_V
Caspase-3(Asp175)_R_V
Beta-Catenin(CT)_R_V
Atg3_R_V
Atg7_R_V
LC3A(D50G8)XP_R_V
LC3B(D11)XP_R_V
p-EGFR(Y845)_R_V
p-EGFR(Y992)_R_V
ErbB2/HER2(Y1248)_R_V
p-SHC(2431)(Y317)_R_V
SRD5A1_R_V
FAS_R_V
HexokinaseII(C64G5)_R_V
PFKFB3 (C-terminal)_R_V
RRM2 (EPR11820)_R_V
p-Stat1(Y701)(D4A7)_R_V
GLDC_R_V
GLS1_R_V
LDHA_R_V
PHGDH_R_V
PKM2_R_V
PKM1/2_R_V
Bcl-xL_R_V
E-Cadherin(24E10)_R_V
ALK(D5F3)XP_R_V
HER2/c-ErbB2_R_V
ALDH_M_V
p-ATM(S1981)_M_V
Axl_M_V
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Company
CST
Santa Cruz Biotechnology
Abcam
Abcam
CST
CST
Abcam
Santa Cruz Biotechnology
CST
Abcam
CST
Abcam
CST
CST
Abcam
CST
CST
CST
Vector Laboratories
CST
CST
CST
CST
CST
CST
CST
CST
CST
Thermo Fisher Scientific
Abcam
CST
CST
CST
CST
Invitrogen
CST
CST
CST
CST
CST
CST
Imgenex
CST
Novusbio
CST
CST
Abcam
Abcam
CST
CST
Proteintech
CST
CST
Bethyl Laboratories
CST
CST
CST
CST
Dako
BD Biosciences
CST
Abcam
(Continued)

Catalog #
13256
sc-1061
ab70450
ab72200
12008
12173
ab70842
sc-585
5348
ab173285
12640
ab60950
7096
9261
ab101841
9308
3590
3281
VP-K451
8440
4705
4711
9699
13166
4707
4292
2603
4249
RM-9101-S1
ab52937
2947
4180
3495
9661
71-2700
3415
8558
4599
3868
2231
2235
IMG-90189
2431
H00006715-D01P
3189
2867
ab135820
ab172476
7649
12794
20170-1-AP
2012
13428
A303-660A-M
3190
2762
3195
3633
A0485
611194
4526
ab54803

Host
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Rabbit
Mouse
Mouse
Mouse
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Table 1. Continued
Antibody name
CD24 Ab2(SN3b)_M_V
Chk2(1C12)_M_V
Cox-2_M_V
GATA3_M_V
GSK-3a/b_M_V
HER2/c-ErbB2-P185_M_V
HIF-1a_M_V
p-IkappaB-a(S32/36)_M_V
S100A7/CBP_M_V
Twist(Twist2C1a)_M_V
SRC-3(clone 1208/D1)_M_V
c-Myc(clone 1123)_M_V
SRC-2(TIF2)_M_V
SRC-1(clone 1135/H4,1136/H4H6)_M_V
PR(1294)_M_V
Rb(4H1)_M_V
p-FAK(Y397)_M_V
AR-441_M_V
AMPKa(F6)_M_V
Bcl2(Clone-124)_M_V
c-Src(B-12)_M_V
IGF-IR(3B7)_M_V
Laminin5_M_V
Aromatase-A(Clone 677H7F10)_M_V
AOX1(cloneAO15)_M_V
IDH2_M_V
SCD1 (CD.E10)_M_V

Company
Thermo Fisher Scientific
CST
BD Biosciences
BD Biosciences
Santa Cruz Biotechnology
Invitrogen (BioSource)
BD Biosciences
BD Biosciences
Abnova
Santa Cruz Biotechnology
BCM-Mab
BCM-Mab
BD
BCM-Mab
Celetta
CST
BD Biosciences
BCM
CST
Dako
Santa Cruz Biotechnology
Santa Cruz Biotechnology
EMD Millipore
BCM-Mab
Sigma-Aldrich
Abcam
Abcam

Catalog #
MS-1279-P0
3440
610203
558686
SC-7291
AHO1011
610958
551818
H00006278-A01
sc-81417
in house
in house
610985
in house
in house_Celetta
9309
611806
NW-Mab70
2793
M088729-2
sc-8056
sc-462
MAB19562
in house
SAB4200562
ab55271
ab19862

Host
Mouse
Mouse
Mouse
Mouse
Mouse
Mouse
Mouse
Mouse
Mouse
Mouse
Mouse
Mouse
Mouse
Mouse
Mouse
Mouse
Mouse
Mouse
Mouse
Mouse
Mouse
Mouse
Mouse
Mouse
Mouse
Mouse
Mouse

Host species for the antibodies and validation status are reported. R, rabbit; M, mouse and V, validated.

c-Fos (1:200, #5348, Cell Signaling Technology), and
c-Jun (1:200, #9261, Cell Signaling Technology), respectively. Fluorescently labeled donkey anti-goat AF488 and
donkey anti-rabbit AF647 were used for detection of
SRC-1 and SRC-2 (1:10,000, Invitrogen), respectively.
Immunoreactive bands were detected and relative optical densities were quantified using a GelDoc Imager
and Image Lab Software (Bio-Rad). Two-way ANOVA followed by Tukey’s honestly significant difference was used
(SPSS v.21) to examine the effect of ligand and receptor
type. We identified differences with Tukey-adjusted
p-values ⬍0.05. In addition, validation of MS findings of
synapsin-I and synapsin-II by Western blot was conducted using a rabbit polyclonal antibody to synapsin-I
(1:500, #ab1543, Millipore, RRID:AB_2200400) and a
mouse monoclonal antibody to synapsin-II (0.3g/mL,
#mabn1573, Millipore). Secondary antibodies donkey
anti-rabbit AF647 and donkey anti-mouse AF488 (1:10,000,
Invitrogen) were used for synapsin-I and synapsin-II, respectively.
In confirmation of findings by RPPA, interaction of PR
with FoxO1 was analyzed by Western blot using a rabbit
polyclonal FoxO1 antibody (1:250, #2880, CST, RRID:
AB_2106495), the same as used for RPPA, followed by a
donkey anti-rabbit AF647 secondary antibody (1:10,000,
Invitrogen). For the detection of mouse GST-PR, a mouse
monoclonal antibody directed against the N-terminal 165–
534 aa of human PR-A and PR-B (PR 1294, 0.5 g/mL),
followed by a donkey anti-mouse AF488 secondary antibody (1:10,000, Invitrogen), was used.
September/October 2017, 4(5) e0272-17.2017

Neuronal cultures
Primary cortical neuronal cultures (mixed sex) were
prepared from Sprague-Dawley rat E18 embryos as described previously (Srivastava et al., 2011). These cortical
cultures display mature neuronal morphology (extensive
arborizations and dendritic spines) and electrophysiological and cellular responses to synaptic activity, consistent
with those seen in in vivo/ex vivo studies of mature neurons (Xie et al., 2007; Srivastava et al., 2012). Because our
MS and RPPA data were collected from mature brain,
cortical neurons, which recapitulate mature neuronal
characteristics (Xie et al., 2007; Srivastava et al., 2012),
were used in these studies.
Animals were habituated for 3 d before experimental
procedures, compliant with the Home Office Animals (Scientific Procedures) Act, UK, 1986. Dissociated cells were
plated onto 18-mm glass coverslips (no. 1.5; 0117580,
Marienfeld-Superior), coated with poly-D-lysine (0.2 mg/
ml, Sigma-Aldrich), at a density of 3 ⫻ 105/well equal to
857/mm2 and cultured in feeding medium: neurobasal
medium (21103049) supplemented with 2% B27 (17504044),
0.5 mM glutamine (25030024), and 1% penicillin:streptomycin (15070063; all reagents from Invitrogen). Neuron
cultures were maintained in the presence of 200 M D,Lamino-phosphonovalerate (D,L-APV, ab120004, Abcam)
beginning on 4 d in vitro (DIV 4) to maintain neuronal
health for long-term culturing and reduce cell death due to
excessive Ca2⫹ cytotoxicity via overactive NMDA receptors (Srivastava et al., 2011). Half-medium changes were
performed twice weekly until the desired age (DIV 23–25).
eNeuro.org
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Pharmacological treatment of neuronal cultures
All pharmacological treatments were performed on DIV
25–30 primary cortical neuronal cultures. Treatments
were conducted in feeding medium: neurobasal medium
(21103049) supplemented with 2% B27, 0.5 mM glutamine, and 1% penicillin:streptomycin in the presence of
200 M D,L-APV. Progesterone (P4; Sigma-Aldrich, P6149)
was dissolved in ethanol to a concentration of 31.8 mM,
and 17␤-estradiol (E2) was dissolved in dimethylsulfoxide
to a final concentration of 1 mM. Both compounds were
serially diluted to a 10⫻ working concentration in feeding
medium and applied directly to neuronal cultures. Final
concentrations of P4 and E2 were 1 nM. Final concentration of solvent was ⬍0.01%: vehicle control was made up
of solvent lacking compound, diluted as test compounds.
Neuronal cultures were treated for 24 h, washed in PBS,
and fixed in 4% formaldehyde/4% sucrose PBS for 10
min at room temperature followed by incubation in methanol prechilled to –20°C for 10 min at 4°C. Fixed neuronal
cultures were then permeabilized and blocked simultaneously (2% normal goat serum, 5425S, Sigma-Aldrich, and
0.2% Triton X-100) before incubation with the following
primary antibodies overnight: PSD95 mouse monoclonal
antibody (1:1000; clone K28/43; #73-028, NeuroMab,
RRID:AB_10698024), synapsin-I rabbit polyclonal antibody (1:200; #5297, Cell Signaling Technologies), and
MAP2 chicken polyclonal antibody (1:2000; #AB104896,
Abcam). Cultures were subsequently incubated with Alexa Fluor anti-rabbit 488, anti-mouse 568, and antichicken 633 secondary antibodies (1:750; Invitrogen) the
following day for 1 h at room temperature (Srivastava
et al., 2011).
Quantitative and statistical analysis of
immunofluorescence
Confocal images of neurons were acquired with a Nikon
A1-R confocal microscope using a 60⫻ oil-immersion
objective (NA 1.4; Nikon) as a z-series, z-step set to 0.5
m. Two-dimensional maximum-projection reconstructions of images were generated, and morphometric analysis (puncta number and intensity) was conducted using
MetaMorph software (Universal Imaging Corporation;
Srivastava et al., 2011). Analyses of puncta were performed on spines from at least two dendrites (secondary
or tertiary branches), totaling 100 m, from each neuron.
The linear density of each synaptic protein cluster was
measured automatically using MetaMorph (Srivastava
et al., 2011). Synaptic puncta were defined as synapsin-I
puncta that contained PSD95 immunofluorescence
greater than background; background fluorescence was
the average background intensity from five regions of
interest plus two standard deviations (Glynn and McAllister, 2006). Cultures that were directly compared were
stained simultaneously and imaged with the same acquisition parameters. For each condition, 10 –16 neurons
from at least 3 separate experiments were used. Experiments were conducted blind to condition and on sister
cultures.
All statistical analyses were performed in GraphPad.
Differences in quantitative immunofluorescence were
September/October 2017, 4(5) e0272-17.2017
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identified by a one-way ANOVA with Tukey correction for
multiple comparisons. Error bars represent the standard
error of the mean.

Results
Mass spectrometry
To detect proteins from female mouse hypothalamus
that associated with mouse PR in the presence or absence of hormone, MS analysis was performed on pulldown samples using GST-tagged PR. This unbiased
approach identified many hypothalamic proteins that interact with one or both PR isoforms in a ligand-dependent
manner (Tables 2 and 2-1). MS-identified proteins were
categorized into the following groups based on their
functions: (a) synaptic structure and function, (b) signal
transduction, (c) transcription, (d) translation, and (e) metabolism. The proteins associated with synaptic structure
and function was the largest group, containing 61% (20 of
35) of the MS-identified proteins that interacted with
ligand-bound PR. Subsets of these synaptic proteins associated with PR-A only (9 proteins), PR-B only (7), or
both isoforms (4) in a ligand-dependent manner, strongly
indicating a function for both PR isoforms in synaptic
physiology. More than 18% (6 of 35) of the identified
PR-interacting proteins are transcriptional regulators, with
two-thirds associating with PR-B only and the remaining
one-third associating with PR-A only. Proteins involved in
signal transduction, including kinases, comprised 9% (3
of 35) of the MS-identified proteins that associated with
PR in the presence of ligand. We also identified the translational regulators 40S ribosomal protein S9 and 26S
protease regulatory subunit 6A that associated only with
PR-B in the presence of R5020. On the other hand, proteins with a role in cellular metabolism identified by MS
interacted with liganded PR-A only (Table 2). Finally, consistent with previous studies (Bagchi et al., 1991; Johnson
and Toft, 1994), a large number of additional proteins
interacted with unliganded PR-A, PR-B, or both
(Table 2-1).
To validate findings by MS, pull-down samples were
analyzed by Western blot for select synaptic proteins, the
largest functional group identified in the MS analysis.
Western blot results showed an increased interaction of
synapsin-Ia and synapsin-Ib with both PR-A and PR-B in
the presence of R5020 compared with no ligand (Fig. 1).
Similarly, the synapsin-II isoforms, synapsin-IIa and
synapsin-IIb, interacted with PR-A and PR-B in a liganddependent manner, further extending the MS findings.
RPPA
To further explore the interactions of proteins from
mouse hypothalamus with PR, we used RPPA, which
provides a targeted approach and allows identification of
phospho-proteins as markers of protein activity. RPPA
analysis identified multiple proteins that interacted with
mouse PR in a ligand-dependent and isoform-specific
manner (Tables 3 and 3-1). In support of the present MS
results, many of the identified proteins that associated
with liganded PR were transcriptional regulators (Table 3).
Additional proteins identified by RPPA that were not deeNeuro.org
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Table 2. Proteins from mouse hypothalamus, identified by MS analysis, associate with mouse PR in a ligand-dependent
manner
Synaptic structure and function

UniProt symbol

Uniprot ID

Synapsin-I
Synapsin-II
Synapsin-III
Synaptogyrin-III
␣-Synuclein
Septin-5
Desmoglein-4
Desmoplakin
Junction plakoglobin
Leucine-rich repeat-containing protein 15
Hemoglobin subunit ␤-1
␤-Actin-like protein 2
Tubulin ␣-1A chain
Tubulin ␣-1B chain
Tubulin ␤-2A chain
Tubulin ␤-3 chain
Tubulin ␤-4A chain
Tubulin ␤-4B chain
Tubulin ␤-5 chain
Tubulin ␤-6 chain
Signal transduction
Mitogen-activated protein kinase 1
14-3-3 protein /␦
Rab GDP dissociation inhibitor ␤
Transcription
Elongation factor 1␤
Histone H4
Brain acid soluble protein 1
Heterogeneous nuclear ribonucleoprotein D-like
Heterogeneous nuclear ribonucleoprotein U-like protein 1
Probable ATP-dependent RNA helicase DDX5
Translation
26S protease regulatory subunit 6A
40S ribosomal protein S9
Metabolism
Creatine kinase B-type
Phytanoyl-CoA hydroxylase-interacting protein-like

SYN1
SYN2
SYN3
SNG3
SYUA
SEPTM5
Desmoglein-4
DESP
PLAK
LGR4
HBB1
ACTBL
TBA1A
TBA1B
TBB2A
TBB3
TBB4A
TBB4B
TBB5
TBB6

O88935
Q64332
Q8JZP2
Q8R191
O55042
Q9Z2Q6
Q7TMD7
E9Q557
Q02257
A2ARI4
P02088
Q8BFZ3
P68369
P05213
Q7TMM9
Q9ERD7
Q9D6F9
P68372
P99024
Q922F4

MK01
1433Z
GDIB

P63085
P63101
Q61598

TIF1B
H4
A4
HNRDL
HNRL1
DDX5

Q62318
P62806
P12023
Q9Z130
Q8VDM6
Q61656

PRS6A
RS9

O88685
Q6ZWN5

KCRB
PHIPL

Q04447
Q8BGT8

PR-A (R5020/no
ligand)
⫹
⫹
⫹
⫹
⫹
⫹
⫹
⫹

⫹
⫹
⫹
⫹
⫹

PR-B (R5020/no
ligand)
⫹
⫹
⫹
⫹
⫹

⫹
⫹
⫹
⫹

⫹
⫹
⫹
⫹
⫹

⫹
⫹

⫹
⫹
⫹
⫹
⫹
⫹

⫹
⫹

Proteins associate with PR with R5020/no ligand at a ratio ⱖ2 and p ⬍ 0.05. Table 2-1 shows proteins identified by MS that associate with PR in the absence of ligand.

tected by MS have known roles in signal transduction or
metabolism; a subset were phosphorylated forms of signaling proteins, including src kinase (Table 3).
Two nuclear receptor coactivators, SRC-1 and SRC-2,
known to be involved in PR expression and function in
brain (Molenda et al., 2002; Molenda-Figueira et al., 2006,
2008; Yore et al., 2010; Acharya et al., 2015), were also
detected by RPPA to interact with PR-A and PR-B in the
presence of R5020 compared with no ligand. Liganddependent interactions with SRC-1 and SRC-2 were further confirmed by Western blot analysis (Fig. 2). Two-way
ANOVA on SRC-1 relative intensity showed an effect of
ligand (F ⫽ 14.56, p ⫽ 10.0 ⫻ 10– 4) such that SRC-1
interacted with PR-A and PR-B in the presence of R5020
compared with no ligand. Similarly, SRC-2 associated
with both PR isoforms when bound to R5020 (F ⫽ 21.65,
p ⫽ 3.0 ⫻ 10–5) compared with no ligand. There were
differences between receptor subtypes on interaction
with either SRC-1 or SRC-2 (Fig. 2). Interestingly, the
September/October 2017, 4(5) e0272-17.2017

majority of proteins that function as transcriptional regulators, as identified by RPPA, interacted with PR-A only
(Table 3). Furthermore, proteins involved in signal transduction identified by RPPA interacted with PR-A, but not
PR-B, in the presence of agonist (Table 3). A transcription
factor with a role in energy metabolism, FoxO1, was also
identified to interact with both PR-A and PR-B. This interaction of FoxO1 with PR was further validated by Western blot (Fig. 3). Confirmation of c-Fos, c-Jun, and
MED12, identified by RPPA, by Western blot was not
possible because the signal intensities of these proteins
by Western were not strong enough to be analyzed, most
likely because of the decreased sensitivity of Western blot
compared with RPPA. Two other proteins identified by
MS to interact with liganded PR, MAP kinase 1 and 14-3-3
protein /␦, were not found to associate with PR in a
ligand-dependent manner by RPPA, likely because of
differences in sensitivities for specific proteins between
the two techniques.
eNeuro.org
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Figure 1. Hypothalamic synapsins interact with mouse PR-A and PR-B in a ligand-dependent manner. Confirmation by Western blot
of MS findings that synapsin-Ia and synapsin-Ib (A) and synapsin-IIa and synapsin-IIb (B) associate with PR-A and PR-B in the
presence, of the PR agonist R5020. Input (0.25% of total) from hypothalamic extracts (lane 1).

Similar to the MS results above, additional proteins that
selectively associated with unliganded PR compared with
their liganded counterparts were identified by RPPA
(Table 3-1).
Ingenuity pathway analysis of PR interactome
Network pathways of proteins that associate with PR,
as identified by MS and RPPA, were created using Ingenuity Pathway Analysis, a program that generates protein
networks using known protein interactions (Fig. 4). The
highest scoring network pathway depicted shows proteins known to associate with PR (e.g., NCOA1 and
NCOA2) and novel interactions of proteins from brain

(e.g., synapsins and tubulin complexes) with PR identified
in the present study (Fig. 4).
The use of the two proteomics approaches, MS and
RPPA, enabled a more comprehensive identification of
novel and known proteins that interacted with PR-A and
PR-B in a ligand-dependent manner. Although MS analysis of PR-protein pull-down assays is an unbiased approach, it is less sensitive than RPPA for detection of
lower-abundance proteins such as SRC-1 and SRC-2.
RPPA, on the other hand, is an antibody-based targeted
proteomic approach and is limited to the target antigens
for which antibodies are available. For example, our RPPA
platform does not have validated antibodies to synaptic

Table 3. Mouse PR-A and PR-B interact with hypothalamic proteins, identified by RPPA, in a ligand-dependent manner, with
a ratio of R5020/no ligand >2 and p < 0.05.
Transcription

UniProt symbol

UniProt ID

Steroid-receptor coactivator-1
Steroid receptor coactivator-2
Thyroid hormone receptor-associated protein complex
c-Fosp
c-Junp
Kruppel-like factor 4
Autophagy-related protein 3
Autophagy related protein 12
BCL2 antagonist/killer 1
Forkhead box O1 (metabolism)
Signal transduction
Src kinasep
Signal transducer and activator of transcription 2p
Epidermal growth factor receptor
p70S6 kinasep
Integrin-␣5
Cyclin C

NCOA1
NCOA2
MED12
FOS
JUN
KLF4
ATG3
ATG12
BAK
FOXO1

P70365
Q61026
A2AGH6
P01101
P05627
Q60793
Q9CPX6
Q9CQY1
O08734
Q9R1E0

PR-A (R5020/no
ligand)
⫹
⫹
⫹
⫹
⫹
⫹
⫹
⫹
⫹
⫹

SRC
STAT2
EGFR
KS6B
ITA5
CCNC

P05480
Q9WVL2
Q01279
Q8BSK8
P11688
Q62447

⫹
⫹
⫹
⫹
⫹
⫹

PR-B (R5020/no
ligand)
⫹
⫹

⫹
⫹

p

Proteins identified with phospho-specific antibodies. Table 3-1 shows proteins identified by RPPA that associate with PR in the absence of ligand.
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Figure 2. SRC-1 and SRC-2 from hypothalamus interact with PR in a ligand-dependent manner. Western blot results show that
SRC-1 (A) and SRC-2 (B) from mouse hypothalamus associate with PR-A and PR-B in the presence of the agonist R5020, but not
in the absence of ligand. ⴱp ⬍ 0.05 indicates difference between the presence and absence of the ligand.

proteins, the largest functional groups identified by MS.
Therefore, MS and RPPA served as complementary approaches for identification of PR-interacting proteins.
Effects of progesterone and estradiol on synapsin-I–
and PSD95-containing synapses
To understand whether P4 could alter synapsin-I levels,
primary rat cortical neurons with a mature morphology
(DIV 23–25) were treated with 1 nM P4, 1 nM E2, or 1 nM P4
and E2 for 24 h. Subsequently, cells were fixed and
immunostained for synapsin-I, postsynaptic density protein 95 (PSD95), and MAP2 (marker of neuronal morphology). Quantitative analysis of immunofluorescence revealed
that after exposure to P4, there was an increase in the
linear density of synapsin-I puncta (Fig. 5A, B). E2, on the
other hand, did not alter synapsin-I linear density from
control (vehicle) levels; the combined treatment of P4 and
E2 also had no effect on synapsin-I levels (synapsin-I

puncta linear density per 10 m: control, 13.0 ⫾ 0.71; P4,
16.6 ⫾ 0.53; E2, 14.2 ⫾ 0.49; P4 ⫹ E2, 11.6 ⫾ 0.58; Fig.
5A, B). When we examined levels of the postsynaptic
protein PSD95, no change in linear density was observed
in cells treated with P4. However, an increase in the
PSD95 linear density was observed in cells treated with
E2 or P4 plus E2 (PSD95 puncta linear density per 10 m:
control, 10.7 ⫾ 0.85; P4, 13.1 ⫾ 0.69; E2, 16.6 ⫾ 0.68;
P4 ⫹ E2, 16.4 ⫾ 0.74; Fig. 5A, C). We next sought to
determine whether the changes in synaptic protein linear
density induced by P4, E2, or P4 plus E2 treatments
reflected an overall change in synapse number; synapses
were defined as synapsin-I puncta overlapping with
PSD95. In line with the observed increases in synapsin-I
and PSD95 linear density in P4- and E2-treated cells, respectively, an increase in synapse number was also observed, whereas the combined treatment of P4 and E2 did
not alter synapse number from control levels (synaptic puncta

Figure 3. Hypothalamic FoxO1 interacts with mouse PR-A and PR-B when bound to the agonist, R5020. Confirmation of RPPA
findings by Western blot that FoxO1 from mouse hypothalamus associates with PR-A and PR-B in the presence, but not the absence,
of the PR agonist R5020. Inputs (1% of total) of FoxO1 from hypothalamic extracts (lane 1).
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Figure 4. Network generated by Ingenuity Pathway Analysis (IPA) showing proteins from hypothalamus that associate with liganded
PR-A and PR-B. Shaded proteins were identified to associate with both PR-A and PR-B (blue), PR-A only (green), or PR-B only
(orange) in the present study. Unshaded proteins (white) were added to the network based on curated relationships in the IPA
database. BAK1, BCL2 antagonist/killer 1; DSP, desmoplakin; JUP, junction plakoglobin; Hbbb1, hemoglobin subunit ␤-1; HNRNPDL,
heterogeneous nuclear ribonucleoprotein D-like; NCOA1/SRC-1, steroid receptor coactivator-1; NCOA2/SRC-2, steroid receptor
coactivator-2; PGR, progesterone receptor; SNCA, ␣-synuclein; SYN, synapsin; TUB, tubulin; YWHAZ, 14-3-3 protein /␦.

linear density per 10 m: control, 9.9 ⫾ 0.80; P4, 14.3 ⫾ 0.49;
E2, 14.2 ⫾ 0.51; P4 ⫹ E2, 12.15 ⫾ 0.59; Fig. 5A, D).

Discussion
Using the proteomics-based approaches of MS and
RPPA, we have identified proteins from female mouse
hypothalamus that form complexes with PR-A, PR-B, or
both in a ligand-dependent manner. Of the proteins that
associated with agonist-bound PR, synaptic modulators
made up the largest group, providing evidence for novel
roles of PR in synaptic plasticity. Furthermore, in primary
cortical neuronal cultures, we provide evidence that progesterone increases synapses containing synapsin-I protein, which selectively associated with ligand-bound PR.
The other major protein groups from hypothalamus that
interacted with the PR isoforms are kinases and signaling
proteins, transcriptional and translational regulators, and
proteins linked to energy metabolism.
PR and synaptic modulation
Progestins modulate dendritic spine density and synapse numbers in the female rat hippocampus, ventromedial hypothalamus (VMH), and prefrontal cortex, and in
September/October 2017, 4(5) e0272-17.2017

cultured rat cortical neurons (Woolley and McEwen, 1993;
McEwen and Woolley, 1994; Chen et al., 2009; Griffin
et al., 2010; Chisholm and Juraska, 2012; Sanchez et al.,
2013). Most prior studies have examined the combined
effects of E2 and P4 on dendritic spines, revealing that E2
increases, whereas E2 plus P4 decreases, dendritic
spines in the hippocampus (McEwen and Woolley, 1994;
Murphy and Segal, 2000), prefrontal cortex (Chisholm and
Juraska, 2012), and hypothalamus (Griffin et al., 2010).
Previously, it has been shown that P4 treatment for 2 wks
increases dendritic spine density in cortical pyramidal
neurons of ovariectomized rats (Chen et al., 2009). The
present findings extended those of Chen et al. (2009) to
reveal that treatment with P4 for 24 h increases synapses
in cortical neurons, as indicated by immunohistochemical
localization of synapsin-I and PSD95 in the newly formed
synapses. In further support of progestin-dependent synapse modulation, estradiol-induced PR have been detected in neuronal processes in the hypothalamus
(Blaustein et al., 1988) and dendritic spines and axon
terminals in the hippocampus (Waters et al., 2008; Mitterling et al., 2010) of female rodents.
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Figure 5. Progesterone (P4) and estradiol (E2) alter synapse number and synaptic protein expression. A, Representative confocal
images of primary rat cortical neurons treated with 1 nM P4, 1 nM E2, or both for 24 h. Images are for synapsin-I (green) and PSD95
(red) along MAP2-positive dendrites (blue). Open arrowheads indicate colocalized synapsin-I and PSD95 puncta and thus, synapses.
B, Quantitative analysis of synapsin-I linear density; treatment with P4 increased synapsin-I density compared with control (vehicle)
condition. C, PSD95 linear density was increased over control levels after treatment with E2 alone or combined P4 and E2 treatment.
D, Measurement of synaptic puncta, defined as synapsin-I puncta positive for PSD95, was increased after treatment with either P4
or E2. ⴱⴱp ⬍ 0.01; ⴱⴱⴱp ⬍ 0.001; scale bar ⫽ 5 m.

The present findings, that synaptic proteins from mouse
brain interact with PR, provide insight into novel mechanisms for progestin effects on synaptic functions. As identified by MS and Western blot, synapsin-I and synapsin-II
interacted with both PR isoforms in a ligand-dependent
manner. In addition, P4 increased synaptic density in rat
primary cortical neurons, indicated by an increase in synapsin-I–positive puncta, suggesting that synapsin-I function in P4-mediated synapse addition is conserved among
species. The present findings confirm the synaptogenic
role of progestins and suggest a function for synapsin-I in
progestin-mediated synapse formation. Synapsins may
influence cortical synapses through direct association
with PR or, alternatively, may function with PR indirectly or
through PR-independent pathways.
Synapsins, including synapsin-I and synapsin-II, are
presynaptic phosphoproteins that are integral in axon
formation, synaptic maturation, transmission, and remodeling in excitatory synapses (Chin et al., 1995; Ferreira
et al., 1998; Bogen et al., 2009; Cesca et al., 2010).
Synapsins contain binding sites for MAPK/Erk and src
kinase (Jovanovic et al., 1996; Foster-Barber and Bishop,
1998), kinases identified in the present study to interact
with ligand-bound PR. Taken together, these findings
suggest that PR increase synapses through regulating
expression, transport, or phosphorylation of synapsins.
Given the rapid effects of estrogens on synapses via
kinases and synaptic proteins (Srivastava et al., 2008;
Sellers et al., 2015), it will be important to explore the
function of kinases identified here on progestin-mediated
synapse formation.
September/October 2017, 4(5) e0272-17.2017

Multiple synaptic proteins interacted with PR in an
isoform-specific manner. For example, synaptogyrin-III,
which is upregulated in the hypothalamus by estradiol
(Malyala et al., 2005), interacted only with PR-A, suggesting a role for this protein in hormone-dependent synaptic
changes. Synapsin-III, which is expressed in cell bodies of
neuronal progenitors and has been implicated in neurogenesis (Kao et al., 2008), interacted only with PR-B,
indicating a role for PR-B in neurogenesis (Barha et al.,
2011; Bali et al., 2012). Interestingly, tubulins, which are
components of microtubules that provide structural
framework for synaptic junctions, postsynaptic densities,
and synaptic vesicles (Kelly and Cotman, 1978; Zisapel
et al., 1980), formed complexes with PR in an isoformspecific and ligand-dependent manner, another novel
finding of the current study. Tubulin␤-2A and tubulin␤-4B,
which are upregulated by estradiol in female hippocampus, were associated with liganded PR in the present
study (Pechenino and Frick, 2009; Sárvári et al., 2015).
Taken together, these findings suggest an important role
for tubulins in progestin-mediated synaptic plasticity in
the brain.
PR and signal transduction
PR, acting through kinase activation, exert rapid effects
in the brain (Mani et al., 2006; Tetel, 2009; Sanchez et al.,
2013). In further support of rapid effects of PR in the brain,
we found that MAPK1 associated with liganded PR-B,
but not PR-A. Consistent with these findings, MAPK1
associates with and phosphorylates PR-B, but not PR-A,
in P4-treated breast cancer cells (Clemm et al., 2000;
eNeuro.org
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Boonyaratanakornkit et al., 2007). In addition, we detected hormone-dependent interactions between src kinase and EGFR with PR-A, but not PR-B. These
differential interactions of signaling molecules with PR
may be important for isoform-specific rapid effects of PR
in brain.
PR and energy metabolism
Although the profound effects of estradiol on decreasing feeding and weight gain and increasing activity in
women and female rodents is well known (Blaustein and
Wade, 1976; Clegg, 2012; Bless et al., 2014, 2016), the
effects of progesterone on metabolism are less studied.
However, progesterone attenuates the effects of estrogens on food intake and carbohydrate metabolism in
female primates and women, respectively (Kemnitz et al.,
1989; D’Eon et al., 2002; Michopoulos and Wilson, 2011).
The present findings reveal that creatine kinase B and
phytanoyl COA-hydroxylase interacting protein-like, both
involved in energy metabolism (James et al., 2012;
Schlattner et al., 2016), associated with PR-A, but not
PR-B, implicating a function for hypothalamic PR-A in
energy homeostasis.
In further support of PR function in energy homeostasis,
the transcriptional regulator FoxO1 interacted with both
PR isoforms. FoxO1 is expressed in energy regulation
centers, including the VMH and arcuate nucleus (Kim
et al., 2006; Fukuda et al., 2008), and enhances food
intake by increasing neuropeptide Y and agouti-related
protein mRNA expression (Kitamura et al., 2006; Huang
et al., 2012). In addition, FoxO1 attenuates leptin signaling
and is regulated by leptin (Yang et al., 2009; Ren et al.,
2013). Taken together with the studies above, the present
findings suggest that hypothalamic PR function in energy
homeostasis and indicate the need for further study of
progestins in food intake and energy metabolism.
PR and transcriptional regulation
PR-A and PR-B act as transcription factors in concert
with other transcriptional regulators, including nuclear receptor coactivators and RNA polymerases (O’Malley
et al., 2012; Tetel and Acharya, 2013; Dasgupta et al.,
2014). The present findings reveal that SRC-1 and SRC-2
from hypothalamus interact with agonist-bound PR-A and
PR-B, consistent with our earlier work that these coactivators are coexpressed with the PR isoforms in the female
mouse hypothalamus (Acharya et al., 2015) and function
in the brain to modulate PR-dependent behaviors (MolendaFigueira et al., 2006).
Although the role of the transcription factor FoxO1 in
energy metabolism is discussed above, it has also been
linked to stress and depression. FoxO1 expression is
upregulated by glucocorticoids (Qin et al., 2014) and is
downregulated by antidepressants (Polter et al., 2009).
Thus, exploring a potential role of FoxO1 and PR interaction may provide more insight into the role of progesterone in stress disorders.
PR-A, but not PR-B, interacted with MED12, which
bridges transcription factors with RNA polymerases and is
integral for vertebrate neuronal development (Wang et al.,
2006; Rocha et al., 2010; Kim et al., 2016). In humans,
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MED12 mutations lead to X-linked mental retardation
(Philibert et al., 2001; Risheg et al., 2007; Schwartz et al.,
2007). Taken together, the present findings provide a
mechanism by which progestins mediate brain development (Quadros et al., 2008; López and Wagner, 2009)
through PRA-MED12 interactions. In future studies, it will
be important to explore whether mutations in MED12
disrupt interactions with PR and alter brain development.
Based on previous studies and the current findings, a
majority of tubulins and synaptic proteins, including synapsin isoforms and ␣-synuclein, likely associate with PR
through a 26S proteasome complex as shown by Ingenuity Pathway Analysis (Fig. 4). Interestingly, 26S protease
subunit associated with PR-B, but not PR-A, in the current
study, suggesting differential downregulation of the PR
isoforms after P4 treatment (Lange et al., 2000). Ingenuity
Pathway Analysis incorporates previously identified proteins that are known to associate with PR, in either the
liganded or unliganded state, with the present findings.
For example, proteins known from previous studies to
interact with PR, including a molecular chaperone hsp90
(DeMarzo et al., 1991; Johnson et al., 1994; Tetel et al.,
1997), actin (known for its role in PR- mediated growth
cone formation and modulation of dendritic spines; Sanchez et al., 2013; Wessel et al., 2014), and nuclear
factor-B (a stress-response regulator; Cutolo et al.,
2004), were added to the network (Fig. 5) by Ingenuity
Pathway Analysis. However, given that the present study
focused on hypothalamic proteins that interact with PR in
a ligand-dependent manner, only these proteins from the
current findings were added to the network (shaded proteins in Fig. 5). In summary, this network confirms previously known interactions of PR with nuclear receptor
coactivators (e.g., SRC-1/NCOA1 and SRC-2/NCOA2)
and provides evidence for novel mechanisms by which
progestins modulate synapses, revealing multiple regulatory levels of PR action in the brain.
Although genome-wide analysis of PR binding sites in
mouse uterus (Rubel et al., 2012) and computational models have been used to predict the human PR interactome
(Liu et al., 2015), to the best of our knowledge, the PR
interactome has not been previously analyzed. Despite
different approaches used in the previous studies (Rubel
et al., 2012; Liu et al., 2015), the present findings of
association of PR with transcriptional regulators, multiple
tubulin isoforms, Src kinase, and EGFR were consistent
with these published reports. Other studies have focused
on receptor-dependent transcriptome or proteome of steroid receptors, including PR and estrogen receptors (Tan
et al., 2012; Yang et al., 2017). Finally, proximity mapping
has been used in cultured cells to identify proteins showing ligand-dependent interactions with receptors for glucocorticoids and androgens (Lempiäinen et al., 2017).
Although these studies have found some interacting partners similar to those of the present study, including
SRC-1, SRC-2, and MED12, none of these experiments
investigated interacting proteins from the brain, and more
specifically the hypothalamus. Therefore, the current
study has identified a number of novel proteins interacting
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with PR, including synaptic proteins and regulators of
metabolism.
A comprehensive and novel approach of combining
MS and RPPA enabled us to identify a diverse and new
group of protein complexes in the brain that interact
with PR in a ligand- and isoform-specific manner. Although MS is an unbiased approach for identification of
novel proteins, it requires large amounts of protein
input, which could result in difficulty identifying lowabundance proteins. RPPA complemented the MS and
expanded the coverage for low-abundance proteins.
Both approaches identified many proteins in three major groups, including those with roles in transcription,
metabolism, and signal transduction. In future studies,
it will be important to investigate interactions between
endogenous hypothalamic PR with proteins using different approaches (e.g., coimmunoprecipitation assays) to confirm and extend the current findings.
Through the identification of multiple components of PR
complexes in the brain, the current study provides insights into various mechanisms of PR in physiology and
disease. In addition, identification of protein complexes
from female mouse hypothalamus that interact differentially with PR-A and PR-B sheds light on mechanisms that
may contribute to PR isoform–specific functions. This
study provides a novel role for synapsin-I in progestininduced increase in synapses. These findings offer further
evidence for overlapping pathways in genomic and nongenomic regulation in synaptic physiology and energy
metabolism. In future studies, it will be important to apply
the present strategies to identify factors involved in
ligand-independent activation of PR (Denner et al., 1990;
Mani et al., 1994; Tetel and Lange, 2009) that will provide
important insights into PR action in physiology, behavior,
and disease.
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